COVID-19 Updates
Feature
COVID emergency over, but hundreds are still dying weekly
Amid widespread efforts to move on and drop protective measures, the country’s most vulnerable people are at significant risk.
News from the FDA/CDC
CDC cuts back hospital data reporting on COVID
“CDC’s authorizations to collect certain types of public health data” expired with the PHE.
Feature
How providers are adjusting to clinical care post PHE
Clinicians will have to fall back on their own policies that patients with potential symptoms mask up. “Now that it’s up to our offices, we have...
Commentary
Clinical trials: Top priority for long COVID
Behavioral treatments including exercise, graded exercise therapy, and cognitive-behavioral therapy should not be trialed, let alone prioritized,...
Latest News
Study of hospitalizations in Canada quantifies benefit of COVID-19 vaccine to reduce death, ICU admissions
Unvaccinated patients were found to be up to 15 times more likely to die from COVID-19 than fully vaccinated patients.
Latest News
COVID-19 and psoriasis: Is there a link?
“Infection with COVID-19 has been associated with flares of guttate and pustular psoriasis, and even psoriasis that affects 100% of the skin.”
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
Latest News
White House to end COVID vaccine mandate for federal workers
The requirement will be lifted at the end of the day on May 11, which is also when the federal public health emergency declaration ends.
Feature
Researchers seek to understand post-COVID autoimmune disease risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
From the Journals
Long-COVID patients respond differently to COVID vaccines
Differences could explain why some people experience symptoms for months while others recover faster.
From the Journals
Trial shows some relief for long COVID fatigue, researchers say
It was one of the first randomized double-blind placebo controlled trial for a possible treatment for long COVID.